Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-048223
Filing Date
2020-04-17
Accepted
2020-04-17 16:31:51
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2016066d1_s3.htm S-3 189033
2 EXHIBIT 5.1 tm2016066d1_ex5-1.htm EX-5.1 13264
3 EXHIBIT 23.1 tm2016066d1_ex23-1.htm EX-23.1 4405
4 GRAPHIC image_001.jpg GRAPHIC 3165
5 GRAPHIC image_002.jpg GRAPHIC 3837
6 GRAPHIC image_004.jpg GRAPHIC 3569
7 GRAPHIC image_003.jpg GRAPHIC 2211
  Complete submission text file 0001104659-20-048223.txt   226075
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237736 | Film No.: 20800120
SIC: 2836 Biological Products, (No Diagnostic Substances)